James Peyer, Director, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 138,000 shares at $4.98 ($687K) on 2021-12-29, disclosed to the SEC on 2021-12-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.98 | 69,000 | $344K | 50.0% |
| 2 | $4.98 | 69,000 | $344K | 50.0% |
| Total | $4.98 avg | 138,000 | $687K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |